| |
| |
|
| Insider
Information: |
Higgins John L |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,806,928 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$48,437,400 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,806,928 |
|
|
| Total
Value |
$48,437,400 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -34.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2022-12-28 |
417,695 |
2007-02-01 |
0 |
Premium* |
|
|
Techne Corp |
TECH |
Director |
2024-05-14 |
36,608 |
2013-10-31 |
0 |
Premium* |
|
|
OmniAb, Inc |
OABI |
Director |
2024-01-30 |
2,352,625 |
2022-11-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
165 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-03-08 |
4 |
D |
$106.92 |
$157,493 |
D/D |
(1,473) |
143,171 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2023-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,625 |
36,608 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-12-08 |
4 |
D |
$87.52 |
$147,296 |
D/D |
(1,683) |
235,087 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2010-06-30 |
4 |
A |
$1.24 |
$2,100 |
D/D |
1,692 |
440,968 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
– • – |
2016-09-08 |
4 |
S |
$109.83 |
$186,716 |
D/D |
(1,700) |
1,359 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-10-13 |
4 |
D |
$143.04 |
$249,462 |
D/D |
(1,744) |
148,811 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-07-31 |
4 |
B |
$95.45 |
$176,583 |
D/D |
1,850 |
146,749 |
2.81 |
- |
|
| TECH |
Techne Corp |
Director |
• • – |
2022-08-10 |
4 |
S |
$373.99 |
$751,194 |
D/D |
(1,992) |
6,014 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2007-06-15 |
4 |
B |
$6.70 |
$13,400 |
D/D |
2,000 |
152,000 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2007-08-13 |
4 |
B |
$5.86 |
$11,720 |
D/D |
2,000 |
154,000 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
President & CEO |
• • – |
2012-12-05 |
4 |
B |
$18.03 |
$36,060 |
D/D |
2,000 |
112,025 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-15 |
4 |
S |
$90.00 |
$180,000 |
D/D |
(2,000) |
367,180 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2017-11-17 |
4 |
S |
$140.34 |
$316,888 |
D/D |
(2,258) |
141,284 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2020-11-09 |
4 |
D |
$81.77 |
$200,991 |
D/D |
(2,458) |
222,113 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-02-15 |
4 |
D |
$85.97 |
$214,237 |
D/D |
(2,492) |
130,497 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-03-13 |
4 |
B |
$114.29 |
$285,725 |
D/D |
2,500 |
141,399 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2019-05-14 |
4 |
B |
$113.50 |
$283,750 |
D/D |
2,500 |
143,899 |
2.81 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-02-05 |
4 |
D |
$203.03 |
$602,999 |
D/D |
(2,970) |
343,060 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-03-06 |
4 |
D |
$165.87 |
$494,624 |
D/D |
(2,982) |
107,419 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2016-09-22 |
4 |
S |
$117.34 |
$352,020 |
D/D |
(3,000) |
122,664 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2021-11-12 |
4 |
S |
$160.50 |
$481,500 |
D/D |
(3,000) |
335,095 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2022-09-16 |
4 |
S |
$89.35 |
$268,050 |
D/D |
(3,000) |
364,180 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-08-16 |
4 |
OE |
$14.47 |
$43,511 |
D/D |
3,007 |
110,426 |
0 |
- |
|
| TECH |
Techne Corp |
Director |
• • – |
2022-08-10 |
4 |
OE |
$66.90 |
$227,460 |
D/D |
3,400 |
8,006 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Chief Executive Officer |
• • – |
2018-08-30 |
4 |
S |
$258.25 |
$903,875 |
D/D |
(3,500) |
85,419 |
0 |
- |
|
165 Records found
|
|
Page 2 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
